Virtual pharmaceutical companies often have strong regulatory and clinical teams, but lack the resources needed to address the complexities of the complete product development and commercialization cycle. Partnering with a contract development and...
Read more ...

While liquid-filled hard capsules (LFHCs) have been around for decades, today’s difficult APIs and increased competition have rekindled interest in this versatile and value-added dosage form. LFHCs’ long list of advantages can have a significant...
Read more ...

Executive Summary There are a range of benefits in using an integrated supplier to streamline biologic drug development starting in early phase through clinical and commercial stages. Partnering with one supplier that understands how to best...

Improvements in raw material inputs are necessary in order to deploy cell & gene therapies economically and at scale. Watch an on-demand webinar featuring Avantor experts to learn about challenges associated with using non-GMP raw materials, as...
Read more ...
Page 1 of 2